Following the outcome of the Scottish referendum, ABPI Scotland, which represents the research-based pharmaceutical industry in the UK, is looking forward to working with all stakeholders to ensure that patients in Scotland get greater, more rapid access to new medicines and the research and business environment supports the growth of the critical medicines sector.Read more
The NICE Board yesterday considered proposals on Value Based Assessment (VBA) following a three month consultation responded to by the Association of the British Pharmaceutical Industry (ABPI).Read more
The Association of the British Pharmaceutical Industry (ABPI) and the Department of Health (DH) have today announced the second quarter payment of £76m by industry to underwrite the growth of the medicines bill under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).Read more
As the ABPI launches an update to its white paper of April 2009 ‘The stratification of disease for personalised medicines’ Dr Louise Leong looks at what has been achieved and what still needs to be done to support a stratified medicine approach in the UK.Read more
Our website is currently experiencing scrolling issues when viewed using Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version of Internet Explorer or use Chrome or Firefox.
Board of Management